Tarceva Safety Questions, Tarceva Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Tarceva side effects. Check out Health Surveys and Health Polls. If you have questions about Tarceva, you can post them to our Doctors or Ask Patient Community about Tarceva.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Tarceva
Tarceva Safety Reports
Total Tarceva reports: 564.Tarceva FDA safety alerts: No.
Reported deaths: 111 Reported hospitalizations: 220.
Take Tarceva Side Effects Survey or Share Your Tarceva Story.
Reported Tarceva Side Effects: diarrhoea, fatigue, dry skin, dehydration, malignant neoplasm progression, cough, respiratory failure, nausea, haemoptysis, rash, rash pustular.
Tarceva Usage.
Showing 1-50 of 564 Next >
Tarceva Side Effects Report #5266092-5Health Professional from UNITED STATES reported TARCEVA problem on Mar 13, 2007. Male patient, 95 years of age, weighting 141.8 lb, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea. TARCEVA dosage: 150MG PO QD PO. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5266886-6
TARCEVA problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5268284-8
Physician from UNITED STATES reported TARCEVA problem on Mar 14, 2007. Female patient, 57 years of age, weighting 217.0 lb, was diagnosed with breast cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: breast cancer metastatic, disease progression, pleural effusion. TARCEVA dosage: 150MG DAILY. During the same period patient was treated with LETROZOLE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5268588-9
TARCEVA problem was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Female patient, weighting 102.0 lb, was diagnosed with breast cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dehydration, presyncope. TARCEVA dosage: 150 MG QD PO. During the same period patient was treated with FEMERA. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5268599-3
Health Professional from UNITED STATES reported TARCEVA problem on Mar 15, 2007. Male patient, weighting 141.8 lb, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction. TARCEVA dosage: 150MG PO - QD PO ON HOLD NOW. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5268860-2
TARCEVA problem was reported by a Consumer or non-health professional from FRANCE on Feb 22, 2007. Male patient, 63 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: vitreous detachment. TARCEVA dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5269922-6
Health Professional from UNITED STATES reported TARCEVA problem on Feb 27, 2007. Male patient, 52 years of age, was diagnosed with brain neoplasm malignant and was treated with TARCEVA. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5271491-1
TARCEVA problem was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 52 years of age, weighting 130.0 lb, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cardiac failure, cardiomyopathy, malignant hypertension. TARCEVA dosage: unknown. During the same period patient was treated with GEMCITABINE, FENTANYL, NEXIUM, SYNTHROID, LASIX, ALBUTEROL, XANAX. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5271862-3
Consumer or non-health professional from CANADA reported TARCEVA problem on Feb 28, 2007. Female patient, 66 years of age, was treated with TARCEVA. TARCEVA dosage: unknown. Patient died.
Tarceva Side Effects Report #5271876-3
TARCEVA problem was reported by a Consumer or non-health professional from CANADA on Mar 01, 2007. Male patient, 57 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer perforation, haematocrit decreased, haemoglobin decreased, mean cell haemoglobin concentration decreased, mean cell haemoglobin decreased, neutrophil count increased, red blood cell count decreased, red cell distribution width increased, white blood cell count decreased. TARCEVA dosage: 100 MG (QD); ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5271877-5
Consumer or non-health professional from BRAZIL reported TARCEVA problem on Mar 01, 2007. Male patient, 42 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: acne, depression, erythema, haemorrhage, rash. TARCEVA dosage: 150 MG (QD); ORAL. Patient recovered.
Tarceva Side Effects Report #5277253-3
TARCEVA problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Female patient, 62 years of age, weighting 122.0 lb, was diagnosed with breast cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cellulitis, staphylococcal bacteraemia. TARCEVA dosage: 150 MG PO DAILY. During the same period patient was treated with FEMARA, MORPHINE SULPHATE, APRAZOLAM, COLACE, ZOMETA, IMODIUM, IBUPROFEN, PEPCID. Patient recovered.
Tarceva Side Effects Report #5278019-0
Physician from GERMANY reported TARCEVA problem on Mar 06, 2007. Female patient was diagnosed with non-small cell lung cancer metastatic and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blood urine present, diarrhoea, nephrolithiasis, renal colic. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5278021-9
TARCEVA problem was reported by a Physician from FRANCE on Mar 06, 2007. Male patient, 50 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform, septic shock. TARCEVA dosage: 150 MG (PO QD), ORAL. During the same period patient was treated with CORTISONE ACETATE, MORPHINE, PREDNISOLONE, MORPHINE SULPHATE, GABAPENTIN. Patient died.
Tarceva Side Effects Report #5286985-2
Pharmacist from FRANCE reported TARCEVA problem on Mar 14, 2007. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, areflexia, interstitial lung disease, muscle spasms, paraesthesia, physical examination abnormal. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, SILOMAT, POTASSIUM CHLORIDE. Patient was hospitalized. Patient died on 12/19/2006.
Tarceva Side Effects Report #5286988-8
TARCEVA problem was reported by a Physician from FRANCE on Mar 15, 2007. Female patient, 46 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: acne, asthenia, dry skin, hypothyroidism. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with LEVOTHYROXINE, MORPHINE SULPHATE, OXAZEPAM, MELODIA. Patient recovered.
Tarceva Side Effects Report #5290686-4
Pharmacist from UNITED STATES reported TARCEVA problem on Apr 05, 2007. Female patient, 46 years of age, weighting 147.7 lb, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hypoaesthesia, muscular weakness, rash. TARCEVA dosage: 150 MG PO QD. During the same period patient was treated with DEXAMETHASONE, MEGACE, ACCUPRIL, DILTIAZEM. Patient recovered.
Tarceva Side Effects Report #5291383-1
TARCEVA problem was reported by a Physician from BELGIUM on Mar 19, 2007. Female patient, 44 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, diarrhoea, disease progression, hepatic neoplasm, non-small cell lung cancer, oesophagitis, procedural complication, rash. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #5292601-6
Physician from ISRAEL reported TARCEVA problem on Mar 22, 2007. Female patient, 61 years of age, was diagnosed with metastatic neoplasm and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: diarrhoea, hepatic encephalopathy. TARCEVA dosage: 150 MG, ORAL. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5292615-6
TARCEVA problem was reported by a Physician from FRANCE on Mar 21, 2007. Female patient, 80 years of age, was diagnosed with lung adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cholestasis, liver disorder. TARCEVA dosage: 150 MG, ORAL. Patient recovered.
Tarceva Side Effects Report #5292616-8
Consumer or non-health professional from GREECE reported TARCEVA problem on Mar 22, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cough, joint stiffness, movement disorder, musculoskeletal stiffness, myalgia. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with PROPRANOLOL. Patient recovered.
Tarceva Side Effects Report #5294678-0
TARCEVA problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Male patient, weighting 149.9 lb, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, ejection fraction decreased, pulmonary embolism, pulmonary hypertension. TARCEVA dosage: 150MG QD PO. During the same period patient was treated with NEBULIZERS, SUD BOOTS. Patient was hospitalized. Patient died on 02/05/2007.
Tarceva Side Effects Report #5294700-1
Health Professional from UNITED STATES reported TARCEVA problem on Apr 09, 2007. Male patient, 95 years of age, weighting 141.8 lb, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, urinary tract infection. TARCEVA dosage: 150MG QD PO. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5301584-1
TARCEVA problem was reported by a Physician from BRAZIL on Mar 27, 2007. Male patient, 42 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: acne, depression, erythema, haemoptysis, poisoning, rash. TARCEVA dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5302861-0
Health Professional from UNITED STATES reported TARCEVA problem on Apr 19, 2007. Male patient, 95 years of age, weighting 141.8 lb, was diagnosed with prostate cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: hernia, intestinal obstruction, refusal of treatment by patient. TARCEVA dosage: 150 MG QD PO. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5304686-9
TARCEVA problem was reported by a Physician from FRANCE on Mar 29, 2007. Female patient, 79 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, melaena. TARCEVA dosage: 100 MG, ORAL. During the same period patient was treated with CORTICOSTEROID NOS, DILTIAZEM, LOVENOX, ISOSORBIDE MONONITRATE, ISOSORBIDE MONONITRATE, ALPHA, POTASSIUM CHLORIDE, PREDNISONE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5307688-1
Consumer or non-health professional from CHINA reported TARCEVA problem on Apr 04, 2007. Female patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: chest pain, cough, dyspnoea. TARCEVA dosage: unknown. Patient died on 03/20/2007.
Tarceva Side Effects Report #5312970-8
TARCEVA problem was reported by a Health Professional from UNITED STATES on Apr 09, 2007. Male patient, 70 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: biliary dilatation, hepatitis acute. TARCEVA dosage: 100 MG QD, ORAL. Patient recovered.
Tarceva Side Effects Report #5313191-5
Physician from UNITED KINGDOM reported TARCEVA problem on Apr 09, 2007. Female patient, 48 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: bipolar i disorder. TARCEVA dosage: 150 MG, ORAL. During the same period patient was treated with STEROID NOS. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5313192-7
TARCEVA problem was reported by a Consumer or non-health professional from CANADA on Apr 09, 2007. Male patient, 62 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder. TARCEVA dosage: unknown. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5313454-3
Pharmacist from UNITED KINGDOM reported TARCEVA problem on Apr 09, 2007. Male patient, 61 years of age, was diagnosed with adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: aspergillosis, cerebral ischaemia, infarction, vascular encephalopathy. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, CARBOPLATIN, CETUXIMAB. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5314152-2
TARCEVA problem was reported by a Physician from GERMANY on Apr 11, 2007. Female patient was diagnosed with hepatic neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: leukocytoclastic vasculitis. TARCEVA dosage: 150 MG (QD). Patient recovered.
Tarceva Side Effects Report #5314153-4
Physician from GERMANY reported TARCEVA problem on Apr 11, 2007. Male patient, 58 years of age, was diagnosed with bile duct cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema, respiratory failure, tachycardia. TARCEVA dosage: unknown. Patient recovered.
Tarceva Side Effects Report #5314748-8
TARCEVA problem was reported by a Physician from IRELAND on Apr 13, 2007. Female patient, 42 years of age, was diagnosed with lung adenocarcinoma and was treated with TARCEVA. TARCEVA dosage: unknown. Patient died on 03/31/2007.
Tarceva Side Effects Report #5314765-8
Health Professional from TAIWAN, PROVINCE OF CHINA reported TARCEVA problem on Apr 13, 2007. Female patient, 67 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: arterial thrombosis limb, respiratory failure. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #5318796-3
TARCEVA problem was reported by a Physician from BELGIUM on Apr 18, 2007. Female patient, 44 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, diarrhoea, gastric disorder, malignant neoplasm progression, non-small cell lung cancer, oesophagitis, purulence. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 02/10/2007.
Tarceva Side Effects Report #5319732-6
Physician from FRANCE reported TARCEVA problem on Apr 17, 2007. Female patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cholestasis. TARCEVA dosage: 100 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5324220-7
TARCEVA problem was reported by a Consumer or non-health professional from CANADA on Apr 20, 2007. Male patient, 63 years of age, was treated with TARCEVA. TARCEVA dosage: unknown. Patient died on 03/30/2007.
Tarceva Side Effects Report #5324532-7
Physician from GERMANY reported TARCEVA problem on Apr 30, 2007. Male patient, 58 years of age, was diagnosed with adenocarcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: pulmonary oedema, respiratory failure, tachycardia. TARCEVA dosage: 100 MG , ORAL. During the same period patient was treated with ESOMEPRAZOLE. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5324533-9
TARCEVA problem was reported by a Consumer or non-health professional from ISRAEL on Apr 24, 2007. Female patient, 52 years of age, was diagnosed with neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: balance disorder, coordination abnormal, dizziness, dysarthria, malignant neoplasm progression. TARCEVA dosage: 150 MG (QD), ORAL. During the same period patient was treated with DANTOIN, DEXAMETHASONE. Patient died on 10/01/2006.
Tarceva Side Effects Report #5325798-X
Physician from THAILAND reported TARCEVA problem on Apr 25, 2007. Female patient, 83 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, leukopenia, lung neoplasm malignant, upper gastrointestinal haemorrhage. TARCEVA dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Tarceva Side Effects Report #5325801-7
TARCEVA problem was reported by a Consumer or non-health professional from CHINA on Apr 25, 2007. Male patient, 49 years of age, was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: chest pain, cough, dyspnoea. TARCEVA dosage: unknown. Patient died on 03/20/2007.
Tarceva Side Effects Report #5328115-4
Health Professional from UNITED STATES reported TARCEVA problem on Apr 26, 2007. Male patient, 67 years of age, was diagnosed with pancreatic carcinoma and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome. TARCEVA dosage: 100 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5328147-6
TARCEVA problem was reported by a Physician from UNITED KINGDOM on Apr 27, 2007. Male patient, 64 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: anisocytosis, blood potassium increased, blood urea increased, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, hyperadrenalism, lung consolidation, lymphadenopathy mediastinal. TARCEVA dosage: unknown. Patient died.
Tarceva Side Effects Report #5328152-X
Physician from GERMANY reported TARCEVA problem on Apr 26, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: balanitis, completed suicide, intertrigo, ulcer. TARCEVA dosage: 150 MG (QD), ORAL. Patient died.
Tarceva Side Effects Report #5328164-6
TARCEVA problem was reported by a Physician from FRANCE on Mar 20, 2007. Female patient, 52 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, diarrhoea, seborrhoeic dermatitis. TARCEVA dosage: 100 MG (QD), ORAL. During the same period patient was treated with CYCLINE NOS. Patient was hospitalized. Patient recovered.
Tarceva Side Effects Report #5328166-X
Consumer or non-health professional from SINGAPORE reported TARCEVA problem on Apr 26, 2007. Female patient, 77 years of age, was diagnosed with lung neoplasm malignant and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: blister, erythema, rash, skin exfoliation. TARCEVA dosage: unknown. During the same period patient was treated with NEUROFORTE. Patient recovered.
Tarceva Side Effects Report #5328167-1
TARCEVA problem was reported by a Physician from MALAYSIA on Apr 26, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, metastases to central nervous system. TARCEVA dosage: 150 MG (QD), ORAL. Patient recovered.
Tarceva Side Effects Report #5328193-2
Consumer or non-health professional from CANADA reported TARCEVA problem on Apr 26, 2007. Male patient, 69 years of age, was diagnosed with neoplasm malignant and was treated with TARCEVA. TARCEVA dosage: unknown. Patient died on 04/15/2007.
Tarceva Side Effects Report #5328353-0
TARCEVA problem was reported by a Pharmacist from UNITED STATES on May 15, 2007. Female patient, 51 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: rash. TARCEVA dosage: 150MG DAILY PO. Patient recovered.
Showing 1-50 of 564 Next >